Cargando…

Atomic structure of the open SARS-CoV-2 E viroporin

The envelope (E) protein of the SARS-CoV-2 virus forms cation-conducting channels in the endoplasmic reticulum Golgi intermediate compartment (ERGIC) of infected cells. The calcium channel activity of E is associated with the inflammatory responses of COVID-19. Using solid-state NMR (ssNMR) spectros...

Descripción completa

Detalles Bibliográficos
Autores principales:	Medeiros-Silva, João, Dregni, Aurelio J., Somberg, Noah H., Duan, Pu, Hong, Mei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for the Advancement of Science 2023
Materias:	Biomedicine and Life Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10575589/ https://www.ncbi.nlm.nih.gov/pubmed/37831764 http://dx.doi.org/10.1126/sciadv.adi9007

Ejemplares similares

Amyloid fibril structures of tau: Conformational plasticity of the second microtubule-binding repeat
por: El Mammeri, Nadia, et al.
Publicado: (2023)

Microtubule-binding core of the tau protein
por: El Mammeri, Nadia, et al.
Publicado: (2022)

Amilorides inhibit SARS-CoV-2 replication in vitro by targeting RNA structures
por: Zafferani, Martina, et al.
Publicado: (2021)

Detecting anti–SARS-CoV-2 antibodies in urine samples: A noninvasive and sensitive way to assay COVID-19 immune conversion
por: Ludolf, Fernanda, et al.
Publicado: (2022)

Aryl hydrocarbon receptor is a proviral host factor and a candidate pan-SARS-CoV-2 therapeutic target
por: Shi, Jiandong, et al.
Publicado: (2023)

The ABC transporter MsbA adopts the wide inward-open conformation in E. coli cells
por: Galazzo, Laura, et al.
Publicado: (2022)

Comparison of replicating and nonreplicating vaccines against SARS-CoV-2
por: Mudrick, Haley E., et al.
Publicado: (2022)

Intermediates in SARS-CoV-2 spike–mediated cell entry
por: Marcink, Tara C., et al.
Publicado: (2022)

Altered host protease determinants for SARS-CoV-2 Omicron
por: Chan, Jasper Fuk-Woo, et al.
Publicado: (2023)

Identification of immunomodulatory drugs that inhibit multiple inflammasomes and impair SARS-CoV-2 infection
por: de Almeida, Letícia, et al.
Publicado: (2022)

Rapid test to assess the escape of SARS-CoV-2 variants of concern
por: Heggestad, Jacob T., et al.
Publicado: (2021)

Tunneling nanotubes provide a route for SARS-CoV-2 spreading
por: Pepe, Anna, et al.
Publicado: (2022)

Microfluidic affinity selection of active SARS-CoV-2 virus particles
por: Gamage, Sachindra S. T., et al.
Publicado: (2022)

Biochemical and structural insights into SARS-CoV-2 polyprotein processing by Mpro
por: Yadav, Ruchi, et al.
Publicado: (2022)

The SARS-CoV-2 spike protein binds and modulates estrogen receptors
por: Solis, Oscar, et al.
Publicado: (2022)

Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors
por: Moghadasi, Seyed Arad, et al.
Publicado: (2023)

Quantitative and ultrasensitive in situ immunoassay technology for SARS-CoV-2 detection in saliva
por: Chen, Yuchao, et al.
Publicado: (2022)

Differential proinflammatory activities of Spike proteins of SARS-CoV-2 variants of concern
por: Tyrkalska, Sylwia D., et al.
Publicado: (2022)

Age-dependent acquisition of pathogenicity by SARS-CoV-2 Omicron BA.5
por: Imbiakha, Brian, et al.
Publicado: (2023)

TREM-2 is a sensor and activator of T cell response in SARS-CoV-2 infection
por: Wu, Yongjian, et al.
Publicado: (2021)

SARS-CoV-2 disrupts respiratory vascular barriers by suppressing Claudin-5 expression
por: Hashimoto, Rina, et al.
Publicado: (2022)

Design of the SARS-CoV-2 RBD vaccine antigen improves neutralizing antibody response
por: Dickey, Thayne H., et al.
Publicado: (2022)

Cell surface SARS-CoV-2 nucleocapsid protein modulates innate and adaptive immunity
por: López-Muñoz, Alberto Domingo, et al.
Publicado: (2022)

Phosphate-mediated coanchoring of RBD immunogens and molecular adjuvants to alum potentiates humoral immunity against SARS-CoV-2
por: Rodrigues, Kristen A., et al.
Publicado: (2021)

Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture system
por: Zhou, Yuyong, et al.
Publicado: (2022)

Structural and computational design of a SARS-CoV-2 spike antigen with improved expression and immunogenicity
por: Williams, James A., et al.
Publicado: (2023)

Intranasal mRNA-LNP vaccination protects hamsters from SARS-CoV-2 infection
por: Baldeon Vaca, Gabriela, et al.
Publicado: (2023)

Protection against SARS-CoV-2 Omicron BA.1 variant challenge in macaques by prime-boost vaccination with Ad26.COV2.S and SpFN
por: Yu, Jingyou, et al.
Publicado: (2022)

Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccination
por: Caniels, Tom G., et al.
Publicado: (2021)

Complete protection by a single-dose skin patch–delivered SARS-CoV-2 spike vaccine
por: McMillan, Christopher L. D., et al.
Publicado: (2021)

Preclinical evaluation of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B
por: Liu, Jun, et al.
Publicado: (2022)

Multivariate mining of an alpaca immune repertoire identifies potent cross-neutralizing SARS-CoV-2 nanobodies
por: Hanke, Leo, et al.
Publicado: (2022)

Microfluidic particle dam for direct visualization of SARS-CoV-2 antibody levels in COVID-19 vaccinees
por: Wu, Minghui, et al.
Publicado: (2022)

Role for N-glycans and calnexin-calreticulin chaperones in SARS-CoV-2 Spike maturation and viral infectivity
por: Yang, Qi, et al.
Publicado: (2022)

Investigating trends in those who experience menstrual bleeding changes after SARS-CoV-2 vaccination
por: Lee, Katharine M. N., et al.
Publicado: (2022)

SARS-CoV-2 Omicron BA.1 and BA.2 are attenuated in rhesus macaques as compared to Delta
por: van Doremalen, Neeltje, et al.
Publicado: (2022)

Pharmacological modulators of epithelial immunity uncovered by synthetic genetic tracing of SARS-CoV-2 infection responses
por: Jiang, Ben, et al.
Publicado: (2023)

Repetitive mRNA vaccination is required to improve the quality of broad-spectrum anti–SARS-CoV-2 antibodies in the absence of CXCL13
por: Azarias Da Silva, Marne, et al.
Publicado: (2023)

Immunological and pathological outcomes of SARS-CoV-2 challenge following formalin-inactivated vaccine in ferrets and rhesus macaques
por: Bewley, Kevin R., et al.
Publicado: (2021)

Integrated immunovirological profiling validates plasma SARS-CoV-2 RNA as an early predictor of COVID-19 mortality
por: Brunet-Ratnasingham, Elsa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ju6fmkk2sv1oihdjt8tqr9mfv4